History 0 7 0 7 O
and 8 11 8 11 O
Physical 12 20 12 20 O
done 21 25 21 25 O
within 26 32 26 32 O
4 33 34 33 34 B-upper_bound
weeks 35 40 35 40 I-upper_bound
of 41 43 41 43 O
enrollment 44 54 44 54 O

History 0 7 55 62 O
of 8 10 63 65 O
hypersensitivity 11 27 66 82 O
to 28 30 83 85 O
the 31 34 86 89 O
contrast 35 43 90 98 O
agent 44 49 99 104 O
perflutren 50 60 105 115 B-allergy_name

History 0 7 116 123 O
of 8 10 124 126 O
pulmonary 11 20 127 136 B-chronic_disease
hypertension 21 33 137 149 I-chronic_disease

Patient 0 7 150 157 O
is 8 10 158 160 O
at 11 13 161 163 O
least 14 19 164 169 O
18 20 22 170 172 B-lower_bound
years 23 28 173 178 I-lower_bound
of 29 31 179 181 O
age 32 35 182 185 B-age

Patient 0 7 186 193 O
with 8 12 194 198 O
primary 13 20 199 206 O
liver 21 26 207 212 B-cancer
tumor 27 32 213 218 I-cancer
or 33 35 219 221 O
metastasis 36 46 222 232 B-cancer
scheduled 47 56 233 242 O
for 57 60 243 246 O
Stereotactic 61 73 247 259 B-treatment
Ablative 74 82 260 268 I-treatment
Radiotherapy 83 95 269 281 I-treatment
( 96 97 282 283 I-treatment
SABR 97 101 283 287 I-treatment
) 101 102 287 288 I-treatment

Patients 0 8 289 297 O
who 9 12 298 301 O
are 13 16 302 305 B-pregnancy
pregnant 17 25 306 314 I-pregnancy
or 26 28 315 317 O
are 29 32 318 321 O
trying 33 39 322 328 O
to 40 42 329 331 O
become 43 49 332 338 B-pregnancy
pregnant 50 58 339 347 I-pregnancy

Performance 0 11 348 359 B-clinical_variable
status 12 18 360 366 I-clinical_variable
( 19 20 367 368 I-clinical_variable
ECOG 20 24 368 372 I-clinical_variable
) 24 25 372 373 I-clinical_variable
between 26 33 374 381 O
0 34 35 382 383 B-lower_bound
- 35 36 383 384 O
3 36 37 384 385 B-upper_bound

